manufacturers of glp-1 drugs What to Make the Coverage and Cost Landscape The Biggest Winner of GLP-1

Gasbjerg LS, Helsted MM, Hartmann B, Jensen MH, Gabe MBN, Sparre-Ulrich AH, et al

The decision affects about 22,000 GIC members who are currently on GLP-1 drugs for weight loss, at a total cost of $46 million, state officials said

Binding and activation of GLP-1R lead to stimulation of pancreatic -cells for a glucose-dependent insulin secretion, suppression of glucagon secretion, gastric emptying delay and reduction in food intake [14,15,16]

It is possible that in the future, a heightened awareness of potential risks due to the ASA guidance will lead to more cautious perioperative management of patients on GLP-1RAs, potentially mitigating future aspiration risk through measures such as extended fasting periods, discontinuation in selected cases, use of gastric ultrasound to identify high-risk patients for pulmonary aspiration, or modified anesthetic techniques

Download Summary Sheet Here

Gut peptide hormones: Importance for food intake